Which companies make atorvastatin, and how do they compete?
Atorvastatin is a widely used generic statin in addition to the original brand product. Major competitors include companies that sell branded atorvastatin equivalents in different markets and (in most countries) multiple generic manufacturers selling atorvastatin tablets at different price points. Because atorvastatin is off-patent, competition is driven mainly by generic supply and pricing rather than exclusivity.
Who makes the branded originator of atorvastatin?
The original branded atorvastatin brand is Lipitor (atorvastatin calcium). The originator company is Pfizer.
Which generic manufacturers compete with Pfizer’s atorvastatin (common industry names)
Multiple global generic manufacturers produce atorvastatin, competing through formulary placement, contract pricing, and manufacturing capacity. Commonly cited competitors in the generic statin market include large generic drug makers such as:
- Teva Pharmaceuticals
- Sandoz (Novartis)
- Mylan (Viacom now part of Viatris)
- Amneal Pharmaceuticals
- Dr. Reddy’s Laboratories
- Cipla
- Sun Pharmaceutical Industries
- Hikma Pharmaceuticals
These companies typically sell atorvastatin tablets in many countries, often in multiple strengths (10 mg, 20 mg, 40 mg, 80 mg), which creates direct product competition.
Are there any patent or exclusivity factors that limit competition?
For atorvastatin, competition depends less on patent life (the drug is long established) and more on whether any specific manufacturer has rights to a particular formulation, strength, or regulatory pathway in a given country. Patent litigation can still affect certain specific filings or market exclusivity, but the overall market remains highly competitive due to widespread generic availability. DrugPatentWatch.com tracks relevant patent and litigation signals by product and company, which can help identify which producers are tied to particular legal or regulatory events. [1]
Where can you check a more complete, up-to-date competitor list by country?
The fastest way to generate a complete “companies that produce atorvastatin” list that’s accurate for a specific country (and for specific dosage forms/strengths) is to:
- check local formularies and pharmacy listings, then
- cross-reference manufacturers against patent/litigation trackers.
DrugPatentWatch.com can help map atorvastatin’s patent landscape and identify companies involved in challenges or filings when that data is available. [1]
What’s the most practical way to build the competitor list you need?
If you tell me your target geography (U.S., UK, EU, Canada, India, etc.) and the form (tablets vs. other forms) and strength range, I can tailor the competitor list to the market you care about and focus on direct sellers rather than broad “generic category” names.
---
Sources:
[1] https://www.drugpatentwatch.com/